EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Enzo Biochem's enterprise value is $3.80 Mil.
Enzo Biochem's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 was $12.81 Mil. Therefore, Enzo Biochem's EV-to-Revenue for today is 0.30.
The historical rank and industry rank for Enzo Biochem's EV-to-Revenue or its related term are showing as below:
ENZ'
s EV-to-Revenue Range Over the Past 10 Years
Min: -10.47 Med: 1.34 Max: 9.47
Current: 0.3
During the past 13 years, the highest EV-to-Revenue of Enzo Biochem was 9.47. The lowest was -10.47. And the median was 1.34.
ENZ's EV-to-Revenue is ranked better than 93.69% of 222
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.355
vs ENZ: 0.30
As of today (2024-05-17), Enzo Biochem's stock price is $1.09.
Enzo Biochem's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 was $0.26. Therefore, Enzo Biochem's PS Ratio for today is 4.26.
Enzo Biochem EV-to-Revenue Historical Data
The historical data trend for Enzo Biochem's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Enzo Biochem's EV-to-Revenue
For the Diagnostics & Research subindustry, Enzo Biochem's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enzo Biochem's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Enzo Biochem's EV-to-Revenue falls into.
Enzo Biochem's current Enterprise Value is $3.80 Mil.
Enzo Biochem's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.81 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enzo Biochem's share price for today is $1.09.
Enzo Biochem's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.26.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enzo Biochem EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Enzo Biochem's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENZ has been successfully added to your 